# Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients

Study · id `cardio:ct-nct02294539` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02294539](<https://clinicaltrials.gov/study/NCT02294539>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02294539

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 231 participants.

## Technical summary

Registry record NCT02294539. Randomized; double masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2016-05-18 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 231 participants (enrolled count; ClinicalTrials.gov record NCT02294539, source copy `cardio:ctgov-nct02294539-2017-03-15`, retrieved 2026-10-26)
- Start date: 2014-08 (registry gives no type) (ClinicalTrials.gov record NCT02294539, source copy `cardio:ctgov-nct02294539-2017-03-15`, retrieved 2026-10-26)
- Primary completion: 2016-05-18 (actual) (ClinicalTrials.gov record NCT02294539, source copy `cardio:ctgov-nct02294539-2017-03-15`, retrieved 2026-10-26)
- Completion: 2016-05-18 (actual) (ClinicalTrials.gov record NCT02294539, source copy `cardio:ctgov-nct02294539-2017-03-15`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT02294539, source copy `cardio:ctgov-nct02294539-2017-03-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02294539-2017-03-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients
- Condition: Hypertension
- Intervention (Drug): Losartan 50mg/amlodipine 5mg
- Intervention (Drug): Losartan 100mg/amlodipine 5mg
- Intervention (Drug): Losartan 50mg/Hydrochlorothiazide 12.5mg
- Intervention (Drug): Losartan 100mg/Hydrochlorothiazide 25mg
- Lead sponsor: Chong-Jin Kim
- Lead sponsor class: OTHER
- Collaborator: Hanmi Pharmaceutical Company Limited
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as a collaborator: Hanmi Pharmaceutical Company Limited (`cardio:org-hanmi-pharmaceutical-company-limited`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparison of 24-Hour Ambulatory Central Blood Pressure Reduction Efficacy Between Fixed Amlodipine or Up-Titrated Hydrochlorothiazide Plus Losartan: The K-Central Study (`cardio:pubmed-31099387`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 2bd98e6f1952002297222a8f7155cb921d0ebff2a6e0232375afc8ccac397e3a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
